Press release
RNAi Technology Market Share & Trends Analysis Report By Form, By Application, By Region And Segment Forecasts 2024-2031 | Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics
RNAi Technology Market || 2024-2031
DataM Intelligence has published a new research report on "RNAi Technology Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/rnai-technology-market
RNAi Technology (RNA interference technology) is a biological process used to silence specific gene expression through the introduction of double-stranded RNA (dsRNA) into a cell. This dsRNA triggers a cellular mechanism that degrades complementary messenger RNA (mRNA) molecules, preventing the translation of the targeted gene into protein. RNAi is a powerful tool for research and therapeutic applications, enabling the study of gene function, the development of gene therapies, and the treatment of various diseases, including cancer and genetic disorders, by selectively inhibiting disease-causing genes.
Key Developments:
On May 18, 2023, Phio Pharmaceuticals Corp., a biotechnology company in the development stage with a proprietary INTASYL RNAi platform, announced pre-clinical data demonstrating that using INTASYL to silence CBL-B and TIGIT can enhance the anti-tumor response of natural killer (NK) cells, leading to more effective cell therapy for cancer treatment.
On April 26, 2023, Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. reported promising preliminary results from the ongoing single ascending dose phase of the ALN-APP Phase 1 study. This investigational RNAi therapy, known as Aln-APP, targets amyloid precursor protein (APP) and is being developed for the treatment of cerebral amyloid angiopathy (CAA) and Alzheimer's disease.
On January 5, 2023, Orbit Identification Limited, a leader in identifying therapeutic peptide hits, entered into a master service agreement with SanegeneBio Inc. (Sanegene), a start-up focused on developing new RNAi-based therapies. The collaboration aims to discover effective delivery methods for various RNA therapies to target specific tissues and effectively silence disease-causing genes.
Research Process:
Both primary and secondary data sources have been used in the global RNAi Technology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
List of the Key Players in the RNAi Technology Market:
Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A
Segment Covered in the RNAi Technology Market:
By Application: Drug discovery and Development, Therapeutics, Drug Delivery, Agriculture, Others
By Type: Micro RNA, Small interfering RNA
By End User: Research and Academic Laboratories, Diagnostic Laboratories
Regional Analysis:
The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rnai-technology-market
Regional Analysis:
The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The RNAi Technology Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of RNAi Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of RNAi Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/rnai-technology-market
Frequently Asked Questions
Q1) How Big is the RNAi Technology Market?
A) Global RNAi Technology Market reached US$ 1.6 billion in 2022 and is expected to reach US$ 3.6 billion by 2031 growing with a CAGR of 10.3% during the forecast period 2024-2031.
Q2) Who are the key players of RNAi Technology Market?
A) The major global players in the RNAi technology market include Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A. among others.
Q3) What are the regions covered in this report?
A) The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa
4) What are the Segments Coverd in this report?
A) The RNAi Technology market is segmented as Type, Diagnosis, Drug Class, Treatment Type, Sales Channel
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Technology Market Share & Trends Analysis Report By Form, By Application, By Region And Segment Forecasts 2024-2031 | Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics here
News-ID: 3674532 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Baked Chips Market industry, Share, In-Depth Qualitative Insights, Explosive Gro …
Global Baked Chips Market reached US$ 1.53 billion in 2022 and is expected to reach US$ 2.34 billion by 2031, growing with a CAGR of 5.4% during the forecast period 2024-2031
DataM Intelligence has published a new research report on "Baked Chips Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product…
Biotechnology Market to Witness Huge Growth by 2031 - F. Hoffmann-La Roche Ltd, …
Biotechnology Market is expected to grow at a CAGR of 15.4% during the forecast period (2024-2031).
DataM Intelligence has published a new research report on "Biotechnology Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this…
Optometry Equipment Market Booming Worldwide With Leading Key Players - Halma Pl …
The Global Optometry Equipment Market reached USD 3.8 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 6.1 billion by 2031. The Global Optometry Equipment Market is expected to exhibit a CAGR of 6.2% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Optometry Equipment Market Size 2024". The report explores comprehensive and insightful Information about various key…
Broadcast Equipment Market Growing Rapidly by 2031- Harmonic Inc., Telefonaktieb …
Global Broadcast Equipment Market Expected to reach a high CAGR By 2031
DataM Intelligence has published a new research report on "Broadcast Equipment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
